Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.46 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | APP | P05067 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MMP2 | P08253 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.36 |
| ▸ | CASP2 | P42575 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | KDM4A | O75164 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6913359 | 0.98 | LMNA (0.44) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL10886005 | 0.88 | APP (0.50) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL28920803 | 0.85 | SLC6A5 (0.53) | LMNACYP2C19SLC6A6BLMAPP | |
| SCHEMBL30407466 | 0.85 | L3MBTL1 (0.47) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL1492162 | 0.83 | LMNA (0.44) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL3899861 | 0.82 | L3MBTL1 (0.39) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL20226746 | 0.81 | CA2 (0.39) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| Zinc Ion SCHEMBL6913362 | 0.80 | L3MBTL1 (0.41) | LMNACYP2C19L3MBTL1CYP2D6CYP3A4 | |
| SCHEMBL3897865 | 0.80 | L3MBTL1 (0.38) | LMNACYP2C19SLC6A6BLML3MBTL1 | |
| SCHEMBL7204674 | 0.80 | CASP2 (0.52) | LMNACYP2C19L3MBTL1CYP2D6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102702039-A | Process for synthesizing beta-alanyl-taurine | UNIV HENAN AGRICULTURAL | 2012-10-03 | — | — | CN | claimed |
| WO-2009097138-A1 | ANTIVIRAL COMPOSITIONS AND METHODS OF TREATMENT | DALOS, LLC (US) | 2009-08-06 | — | — | WO | claimed |
| US-20090076132-A1 | ANTIVIRAL COMPOSITIONS AND METHODS OF TREATMENT | PEKOE GARY | 2009-03-19 | — | — | US | claimed |
| CN-101291679-A | Compositions comprising actinidia and methods of use thereof | EFFICAS INC PANGENOMICS CO LTD (US) | 2008-10-22 | — | — | CN | claimed |
| WO-1999042097-A1 | SMALL MOLECULES THAT ELICIT A POLARIZED TH1 RESPONSE AND FOR MODULATION OF CELLULAR IMMUNITY | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | claimed |
| US-20240041802-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | AXON CONNECTED, LLC | 2024-02-08 | — | — | US | disclosed |
| US-11672771-B2 | Beta-alethine, immune modulators, and uses thereof | AXIMMUNE, INC. (US) | 2023-06-13 | — | — | US | disclosed |
| US-20200069616-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | AXON CONNECTED, LLC | 2020-03-05 | — | — | US | disclosed |
| EP-3534933-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | Aximmune, Inc. (US) | 2019-09-11 | — | — | EP | disclosed |
| US-9655870-B2 | Homeopathic drug composition and methods of use thereof | FINDCURE.ORG (US) | 2017-05-23 | — | — | US | disclosed |
| CN-102702039-A | Process for synthesizing beta-alanyl-taurine | UNIV HENAN AGRICULTURAL | 2012-10-03 | — | — | CN | disclosed |
| CN-102702039-A | Process for synthesizing beta-alanyl-taurine | UNIV HENAN AGRICULTURAL | 2012-10-03 | — | — | CN | disclosed |
| US-6096536-A | COMPOUNDS SUPPORT CELL VITALITY AND PROVIDE INCREASED CELLULAR LIFE SPAN, INCREASED CELLULAR BIOPRODUCTIVITY, IMPROVED CELLULAR FUNCTION, AND ADAPTION OF RESISTANT CELLS TO CULTURING | UNIVERSITY OF NEW MEXICO (US) | 2000-08-01 | — | — | US | disclosed |
| US-6007819-A | Methods of inducing immunity using low molecular weight immune stimulants | DOVETAIL TECHNOLOGIES, INC. (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999042099-A1 | LOW MOLECULAR WEIGHT COMPOUNDS ADMINISTERED TOGETHER WITH ANTI-CANCER AGENTS TO TREAT CANCER AND PHARMACEUTICAL COMPOSITIONS THEREOF | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999042116-A1 | NOVEL DISULFIDES AND THIOL COMPOUNDS | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1999042097-A1 | SMALL MOLECULES THAT ELICIT A POLARIZED TH1 RESPONSE AND FOR MODULATION OF CELLULAR IMMUNITY | DOVETAIL TECHNOLOGIES INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| WO-1997014306-A1 | LOW MOLECULAR WEIGHT CELL, BONE MARROW AND IMMUNE STIMULANTS | DOVETAIL TECHNOLOGIES, INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| US-5578313-A | Therapeutic use of vitaletheine modulators in neoplasia | THE UNIVERSITY OF NEW MEXICO (US) | 1996-11-26 | — | — | US | disclosed |
| US-4218404-A | HYPOGLYCEMIC AGENTS | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1980-08-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672771-B2 | Beta-alethine, immune modulators, and uses thereof | CD58, FUT4, FUT8 | LMNA 3384/4885CYP2C19 4361/4885SLC6A6 2763/4885 |
| US-20240041802-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | CD58, FUT4, FUT8 | LMNA 3384/4885CYP2C19 4361/4885SLC6A6 2763/4885 |
| US-20200069616-A1 | BETA-ALETHINE, IMMUNE MODULATORS, AND USES THEREOF | CD58, FUT4, FUT8 | LMNA 3384/4885CYP2C19 4361/4885SLC6A6 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.